The Maryland Stem Cell Research Fund (MSCRF) is focused on identifying and fostering cutting-edge research and innovation in the field of regenerative medicine in Maryland. Our Accelerating Cures initiative comprises programs that help transition human stem cell-based technologies from the bench to the bedside as well as mechanisms to build and grow stem cell companies in Maryland. Since 2007, MSCRF has invested over $164 million in accelerating stem cell research, cures and commercialization, in addition to building a collaborative stem cell community in our region. Below is a list of our most current awardees.

2021

2020

2019

2018

Annual Reports

Annual reports include profiles and details on past MSCRF awardees, the MSCR Commission, and closed grant awardees.